Synthace

We're excited to share that we've ranked in the top 50 on the Great Place To Work UK Best Workplaces for Women list!

At Synthace, we empower each employee to live authentically at work, and to thrive while doing so. This ranking is a significant step in building an inclusive culture and bridging the gender gap in the life sciences.

Thank you to our team for participating in this annual survey and helping us create a better workplace for all!

Learn more: https://www.greatplacetowork.co.uk/workplace/item/5128/Synthace

No scientist enjoys the trial and error involved with finding the right number, and concentration, of stocks.

Like so many tasks in biology, it can make you suffer from a kind of “Goldilocks Syndrome”.

You shift your focus away from your experiment and you obsess over making sure that your stock liquids are, as the curious blonde in The Three Bears puts it, “just right”.

Small enough to fit in the final total volume, at the specified final concentration, but large enough to pipette accurately.

This becomes particularly problematic when you’re planning a complex Design of Experiments (DOE) design.

Nuno Leitão, Principal Research Scientist at Synthace, dives into why stock solution calculations and complex DOEs don't mix, and what you can do about it:

DOE Without Math: Stock Solutions Calculated for You - Synthace Principal Scientist Nuno explains how Synthace DOE automatically adjusts all your stock solution calculations as you modify your DOE design.

Synthace is excited to release a new DOE tool that any biologist can use, regardless of experience. Unlock the power of more sophisticated, efficient, and impactful experiments with your existing lab setup.

If you’ve ever wondered if you’re running the best possible version of your experiment, or if you keep hitting dead ends in campaigns that yield inconclusive results, Synthace DOE can help.

Our Product Marketing Manager, Sam Oliver, details everything you need to know about our latest product, and how you can apply it to your own experiments to generate high-impact results, faster:

A Design of Experiments tool that anyone can use | Synthace DOE Sam Oliver, Product Marketing Manager at Synthace, details our latest product development - the only DOE tool built for biologists, by biologists.

has been hailed as the next big thing in but to leverage its full potential, the industry first needs to pay attention to and collection. Learn more in our recent article published by Labiotech.eu👉https://hubs.la/H0Wv3QR0

Cloud Foundations for R&D: Designing the Future of Life Sciences To leverage the potential of AI the life sciences industry needs to pay attention to experimental design and cloud-based data collection.

What’s next for R&D in this age and how can your organization leverage digital to deliver deeper that helps you select high-quality drug candidates and more quickly identify which might succeed or fail?

See our five-step guide that will help you and your team determine the best possible digital environment to accelerate your day-to-day R&D work, as well as deliver organization-wide 👉https://hubs.la/H0Wn9vf0

What’s next for R&D in this age and how can your organization leverage digital to deliver deeper that helps you select high-quality drug candidates and more quickly identify which might succeed or fail?

See our five-step guide that will help you and your team determine the best possible digital environment to accelerate your day-to-day R&D work, as well as deliver organization-wide 👉https://hubs.ly/H0W9Q2V0

Has the astounding pace of the COVID vaccine development set new expectations for drug development timelines?

Our CSO and Co-Founder, Markus Gershater, discusses if we've really arrived at a new normal, and how we need to apply what we've learned to the discovery and development of future therapeutics. Read the blog to find out more👉https://www.synthace.com/covid-vaccine-development-astonishing-but-therapeutics-discovery-and-development-not-solved/

COVID Vaccine Development was Astonishing, but Therapeutics Discovery and Development aren’t Solved - Synthace Our CSO and Co-Founder discusses the astounding pace of the COVID vaccine development and how we need to apply what we've learned to future R&D.

: The increasingly complex problems in biological can be addressed with tools such as .

But to utilize machine learning to its full potential in order to address complex biological questions, we must be able to build a strong foundation of well contextualized in biological . Read our blog to find out where to start👉https://www.synthace.com/machine-learning-its-all-about.../

Machine Learning: It’s All About the Data - Synthace How to build a strong data foundation for machine learning applications.

What’s next for R&D in this age and how can your organization leverage digital to deliver deeper that helps you select high-quality drug candidates and more quickly identify which might succeed or fail?

See our five-step guide that will help you and your team determine the best possible digital environment to accelerate your day-to-day R&D work, as well as deliver organization-wide 👉https://hubs.la/H0Vx_GS0

The increasingly complex problems in biological can be addressed with tools such as .

But to utilize machine learning to its full potential in order to address complex biological questions, we must be able to build a strong foundation of well contextualized in biological . Read our blog to find out where to start👉https://www.synthace.com/machine-learning-its-all-about-the-data/

Machine Learning: It’s All About the Data - Synthace How to build a strong data foundation for machine learning applications.

"We really need to digitize and move research to the cloud to set science free, and allow everyone to be able to interact with it everywhere," Guy Levy-Yurista, CEO of Synthace, told Forbes.

: John Cumbers and Lana Bandoim covered the release of the Synthace Life Sciences R&D Cloud, the first ever no-code software platform for automating experimentation and insight sharing.

Read on to learn more about how our platform is transforming life sciences R&D👉https://www.forbes.com/sites/johncumbers/2021/08/11/why-is-science-still-on-spreadsheets-meet-the-company-moving-biology-into-the-cloud/?sh=4f22153c76b9

Why Is Science Still On Spreadsheets? Meet The Company Moving Biology Into The Cloud Synthace announced the first life sciences research and development (R&D) cloud that includes no-code software.

What’s next for R&D in this age and how can your organization leverage digital to deliver deeper that helps you select high-quality drug candidates and more quickly identify which might succeed or fail?

See our five-step guide that will help you and your team determine the best possible digital environment to accelerate your day-to-day R&D work, as well as deliver organization-wide 👉https://hubs.la/H0V872G0

"The is here, the is underway. The best is yet to come!"

: Our CEO Guy Levy-Yurista sat down with Technology Networks to discuss the barriers to life scientists currently face and the importance of effective and tools to support powerful experimentation and rapid, confident decision-making.

"This decade is going to be the decade of biotechnology, genetics, genomics and all the adjacent areas. And the of life sciences is already in progress with more adoption of cloud-based platforms, as well as a general consensus amongst scientists that an open ecosystem of collaborative hardware and software providers will be the only way for our industry to keep evolving for the better.”

Click here for the full interview👉https://www.technologynetworks.com/informatics/blog/a-no-code-cloud-platform-for-life-science-research-351591

A No-Code Cloud Platform for Life Science Research Technology Networks spoke to Guy Levy-Yurista, CEO of Synthace to find out how the new cloud-based solution can support life science research.

Synthace updated their business hours.

Synthace added a button to help you learn more about them.

Synthace updated their info in the about section.

: Today we announced our new Synthace Life Sciences R&D Cloud, the first ever no-code platform that lowers the barriers to automated biological experimentation and insight sharing. Read the press release to learn more👉https://www.synthace.com/synthace-unveils-first-life.../

Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists - Synthace First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.

Synthace updated their phone number.

We’re thrilled to announce our new Synthace Life Sciences R&D Cloud, the first ever no-code platform that lowers the barriers to automated biological experimentation and insight sharing. Read the press release to learn more👉https://www.synthace.com/synthace-unveils-first-life-sciences-rd-cloud-addressing-complexity-speed-reproducibility-for-scientists/

Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists - Synthace First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.